Zydus Lifesciences has filed a disclosure regarding a change in the promoter group’s shareholding. On May 25, 2026, 10,000 equity shares were transmitted from the late Jasodaben Babubhai Patel to Mr. Samar Babubhai Patel, both members of the promoter group. This transmission, facilitated via an off-market transaction, adjusted the shareholding percentages accordingly, maintaining the promoter group’s overall control of the company.
Key Shareholding Disclosure by Zydus Lifesciences
Zydus Lifesciences Limited has officially notified stakeholders about a significant transmission of equity shares within its promoter group. This disclosure, dated May 26, 2026, details a change initiated on May 25, 2026, involving the transfer of shares due to the passing of a promoter group member.
Details of Share Transmission
The transmission involved 10,000 equity shares of Zydus Lifesciences. These shares were transferred from the holdings of the late Jasodaben Babubhai Patel to Mr. Samar Babubhai Patel. Both individuals are recognized as members of the promoter group of the company. The transmission was executed as an off-market transaction, indicating it did not occur through a public stock exchange.
Impact on Shareholding
Following the transmission, Mr. Samar Babubhai Patel’s shareholding increased. Prior to this transaction, he held 0 equity shares representing 0.00% of the company’s total shareholding. Post-transmission, his holding now stands at 10,000 equity shares, also representing 0.00% of the total shareholding due to the scale of the total outstanding shares. The effective date for the acquisition of these shares by Mr. Patel was May 22, 2026, with the intimation to the company completed by May 25, 2026.
Source: BSE
